Brief: Tarsus To Ring Nasdaq Stock Market Closing Bell In Celebration Of The Launch Of Xdemvy
06/09/2023 16:17
Sept 6 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS TO RING NASDAQ STOCK MARKET CLOSING BELL IN
CELEBRATION
OF THE LAUNCH OF XDEMVY™, THE FIRST AND ONLY FDA APPROVED
TREATMENT FOR DEMODEX BLEPHARITIS
Source text for Eikon: ID:nGNX4QY57h
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)